Nitrofurantoin: Difference between revisions

(Text replacement - "Category:Drugs" to "Category:Pharmacology")
No edit summary
Line 1: Line 1:
==General==
==General==
*Type:  
*Type: [[Antibiotic]]
*Dosage Forms:
*Dosage Forms: oral
*Common Trade Names:  
*Common Trade Names: Macrobid


==Adult Dosing==
==Adult Dosing==
*Monohydrate/macrocrystals (Macrobid): 100mg PO q12h
*Macrocrystals: 50-100mg PO 4 times daily


==Pediatric Dosing==
==Pediatric Dosing==
*>12yo: same as above


==Special Populations==
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]:
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: B
*Lactation:
*Lactation Risk: Infant risk minimal
*Renal Dosing
*Renal Dosing: Contraindicated if CrCl <60
**Adult
*Hepatic dosing:
**Pediatric
*Hepatic Dosing
**Adult
**Pediatric


==Contraindications==
==Contraindications==
*Allergy to class/drug
*Allergy to class/drug
 
*Neonates, pregnant women at term or when delivery imminent
==Adverse Reactions==
==Adverse Reactions==
===Serious===
===Serious===
*Hemolytic anemia can occur in patients with G6PD deficiency and in infants less than 1 month old
*Hemolytic anemia can occur in patients with G6PD deficiency and in infants less than 1 month old
 
*Hepatic necrosis, hepatitis, cholestatic jaundice syndrome
*Erythema multiforme/SJS
*Pancreatitis
*Peripheral neuropathy
*Pulmonary hypersensitivity
===Common===
===Common===
*Nausea
*Headache
*Hemolytic anemia


==Pharmacology==
==Pharmacology==
Line 31: Line 37:
*Metabolism:  
*Metabolism:  
*Excretion:  
*Excretion:  
*Mechanism of Action:
*Mechanism of Action: Inactivates bacterial ribosomal proteins


==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==
==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==

Revision as of 21:08, 10 November 2016

General

  • Type: Antibiotic
  • Dosage Forms: oral
  • Common Trade Names: Macrobid

Adult Dosing

  • Monohydrate/macrocrystals (Macrobid): 100mg PO q12h
  • Macrocrystals: 50-100mg PO 4 times daily

Pediatric Dosing

  • >12yo: same as above

Special Populations

  • Pregnancy Rating: B
  • Lactation Risk: Infant risk minimal
  • Renal Dosing: Contraindicated if CrCl <60
  • Hepatic dosing:

Contraindications

  • Allergy to class/drug
  • Neonates, pregnant women at term or when delivery imminent

Adverse Reactions

Serious

  • Hemolytic anemia can occur in patients with G6PD deficiency and in infants less than 1 month old
  • Hepatic necrosis, hepatitis, cholestatic jaundice syndrome
  • Erythema multiforme/SJS
  • Pancreatitis
  • Peripheral neuropathy
  • Pulmonary hypersensitivity

Common

  • Nausea
  • Headache
  • Hemolytic anemia

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:
  • Mechanism of Action: Inactivates bacterial ribosomal proteins

Antibiotic Sensitivities[1]

Group Organism Sensitivity
Gram Positive Strep. Group A, B, C, G S
Strep. Pneumoniae S
Viridans strep X1
Strep. anginosus gp X1
Enterococcus faecalis S
Enterococcus faecium S
MSSA S
MRSA S
CA-MRSA S
Staph. Epidermidis X1
C. jeikeium R
L. monocytogenes X1
Gram Negatives N. gonorrhoeae S
N. meningitidis X1
Moraxella catarrhalis X1
H. influenzae X1
E. coli S
Klebsiella sp I
E. coli/Klebsiella ESBL+ X1
E coli/Klebsiella KPC+ R
Enterobacter sp, AmpC neg I
Enterobacter sp, AmpC pos I
Serratia sp X1
Serratia marcescens R
Salmonella sp S
Shigella sp S
Proteus mirabilis X1
Proteus vulgaris R
Providencia sp. X1
Morganella sp. X1
Citrobacter freundii X1
Citrobacter diversus X1
Citrobacter sp. X1
Aeromonas sp X1
Acinetobacter sp. X1
Pseudomonas aeruginosa R
Burkholderia cepacia R
Stenotrophomonas maltophilia R
Yersinia enterocolitica X1
Francisella tularensis X1
Brucella sp. X1
Legionella sp. X1
Pasteurella multocida X1
Haemophilus ducreyi X1
Vibrio vulnificus X1
Misc Chlamydophila sp R
Mycoplasm pneumoniae X1
Rickettsia sp X1
Mycobacterium avium X1
Anaerobes Actinomyces X1
Bacteroides fragilis X1
Prevotella melaninogenica X1
Clostridium difficile X1
Clostridium (not difficile) X1
Fusobacterium necrophorum X1
Peptostreptococcus sp. X1

Key

  • S susceptible/sensitive (usually)
  • I intermediate (variably susceptible/resistant)
  • R resistant (or not effective clinically)
  • S+ synergistic with cell wall antibiotics
  • U sensitive for UTI only (non systemic infection)
  • X1 no data
  • X2 active in vitro, but not used clinically
  • X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
  • X4 active in vitro, but not clinically effective for strep pneumonia

See Also

Source

  1. Sanford Guide to Antimicrobial Therapy 2014